{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:07:25Z","timestamp":1783937245023,"version":"3.55.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>For an adolescent with physical disabilities, intellectual disabilities, or both, and for her caregivers, menstruation can present significant challenges. If, after an evaluation, the adolescent, her family, and the obstetrician\u2013gynecologist have decided that menstrual intervention is warranted, advantages and disadvantages of hormonal methods should be reviewed and individualized to each patient\u2019s specific needs. Complete amenorrhea may be difficult to achieve, and realistic expectations should be addressed with the patient and her caregivers. The goal in menstrual manipulation should be optimal suppression, which means a reduction in the amount and total days of menstrual flow. Menstrual suppression before menarche and endometrial ablation are not recommended as treatments. Optimal gynecologic health care for adolescents with disabilities is comprehensive; maintains confidentiality; is an act of dignity and respect toward the patient; maximizes the patient\u2019s autonomy; avoids harm; and assesses and addresses the patient\u2019s knowledge of puberty, menstruation, sexuality, safety, and consent.<\/jats:p>","DOI":"10.1097\/aog.0000000000001585","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T19:48:08Z","timestamp":1469648888000},"page":"e20-e25","source":"Crossref","is-referenced-by-count":51,"title":["Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities"],"prefix":"10.1097","volume":"128","member":"276","reference":[{"key":"R1-20230711","first-page":"217","article-title":"ACOG Committee Opinion No. 371. American College of Obstetricians and Gynecologists","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/AOG.0000000000000387","article-title":"Menstrual and reproductive issues in adolescents with physical and developmental disabilities","volume":"124","author":"Quint","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000001215","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Committee Opinion No. 651. American College of Obstetricians and Gynecologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3104\/reviews.95","article-title":"Down syndrome and thyroid disorders: a review","volume":"6","author":"Prasher","year":"1999","journal-title":"Downs Syndr Res Pract"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1528-1157.2001.33500.x","article-title":"Valproate and the polycystic ovarian syndrome: final thoughts","volume":"42","author":"Herzog","year":"2001","journal-title":"Epilepsia"},{"key":"R6-20230711","first-page":"e1","article-title":"Practice Bulletin No. 157. American College of Obstetricians and Gynecolo-gists","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/01.AOG.0000445581.43112.41","article-title":"Committee Opinion No. 592. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.313.7057.579","article-title":"Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid","volume":"313","author":"Bonnar","year":"1996","journal-title":"BMJ"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/AOG.0b013e318197bda9","article-title":"Confronting the legal risks of prescribing the contraceptive patch with ongoing litigation","volume":"113","author":"Phelps","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/107602960200800212","article-title":"Oral contraceptives and venous thromboembolism: which are the safest preparations available?","volume":"8","author":"Girolami","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"key":"R12-20230711","article-title":"Cyclical progestogens for heavy menstrual bleeding. Cochrane Database of Systematic Reviews","author":"Lethaby","year":"2008"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/GCO.0000000000000098","article-title":"Menstrual suppression for adolescents","volume":"26","author":"Altshuler","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpag.2013.09.002","article-title":"Retrospective review of norethindrone use in adolescents","volume":"27","author":"Santos","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R16-20230711","first-page":"1398","article-title":"Committee Opinion No. 602. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R18-20230711","first-page":"206","article-title":"Practice Bulletin No. 110. American College of Obstetricians and Gynecologists","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.61.6_suppl_2.S2","article-title":"Catamenial epilepsy: pathophysiology, diagnosis, and management","volume":"61","author":"Foldvary-Schaefer","year":"2003","journal-title":"Neurology"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1196\/annals.1429.020","article-title":"Menstrual issues in adolescents with physical and developmental disabilities","volume":"1135","author":"Quint","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl 2","key":"R21-20230711","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3949\/ccjm.71.Suppl_2.S11","article-title":"Hormones and seizures","volume":"71","author":"Foldvary-Schaefer","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Implanon US Study Group","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpag.2015.05.003","article-title":"Adolescents with special needs: clinical challenges in reproductive health care","volume":"29","author":"Quint","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","article-title":"Trends in menstrual concerns and suppression in adolescents with developmental disabilities","volume":"53","author":"Kirkham","year":"2013","journal-title":"J Adolesc Health"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/01443610500040745","article-title":"Pregnancy following endometrial ablation: a review article","volume":"25","author":"Hare","year":"2005","journal-title":"J Obstet Gynaecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201608000-00054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:07:52Z","timestamp":1689088072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201608000-00054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001585","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}